In Vitro Antifungal Susceptibility of the Emerging Multidrug-Resistant Pathogen Candida auris to Miltefosine Alone and in Combination with Amphotericin B

Antimicrob Agents Chemother. 2020 Jan 27;64(2):e02063-19. doi: 10.1128/AAC.02063-19. Print 2020 Jan 27.

Yongqin Wu^{1

2}, Marissa Totten², Warda Memon³, Chunmei Ying¹, Sean X Zhang^{4

3}

¹ Department of Clinical Laboratory, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
² Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
³ Microbiology Laboratory, Johns Hopkins Hospital, Baltimore, Maryland, USA.
⁴ Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA szhang28@jhmi.edu.

No abstract available

Keywords: Candida auris; antifungal activity; antifungal agents; antifungal susceptibility testing; miltefosine; synergy.

Publication types